165 Label-free autofluorescence lifetime to assess changes in myocardial fibrosis and metabolism in vivo in a doxorubicin cardiomyopathy heart failure model
165 Label-free autofluorescence lifetime to assess changes in myocardial fibrosis and metabolism in vivo in a doxorubicin cardiomyopathy heart failure model